Anti–ETAR autoantibodies can be used together with the presence of current or past DU to identify patients with SSc who are at risk for the development of subsequent DU. PubMed, 08/01/2015. (Also see Digital Ulcers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.